BSF Enterprise Plc (BSFA) - Total Liabilities

Latest as of September 2025: GBX289.02K GBX ≈ $35.16 USD

Based on the latest financial reports, BSF Enterprise Plc (BSFA) has total liabilities worth GBX289.02K GBX (≈ $35.16 USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of BSF Enterprise Plc to assess how effectively this company generates cash.

BSF Enterprise Plc - Total Liabilities Trend (2019–2025)

This chart illustrates how BSF Enterprise Plc's total liabilities have evolved over time, based on quarterly financial data. See what is BSF Enterprise Plc's book value for net asset value and shareholders' equity analysis.

BSF Enterprise Plc Competitors by Total Liabilities

The table below lists competitors of BSF Enterprise Plc ranked by their total liabilities.

Company Country Total Liabilities
Futura Medical
LSE:FUM
UK GBX2.44 Million
Physiomics Plc
LSE:PYC
UK GBX165.00K
Gaming Technologies Inc. Common Stock
NASDAQ:GMGT
USA $5.17 Million
FAT Brands Inc
NASDAQ:FATBW
USA $1.79 Billion
Hsin Yung Chien Co Ltd
TW:2114
Taiwan NT$597.24 Million
Marechale Capital Plc
LSE:MAC
UK GBX123.20K
Technology Minerals PLC
LSE:TM1
UK GBX7.28 Million
Botswana Diamonds plc
LSE:BOD
UK GBX1.17 Million

Liability Composition Analysis (2019–2025)

This chart breaks down BSF Enterprise Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BSFA company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.70 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.11 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.10 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BSF Enterprise Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BSF Enterprise Plc (2019–2025)

The table below shows the annual total liabilities of BSF Enterprise Plc from 2019 to 2025.

Year Total Liabilities Change
2025-09-30 GBX289.02K
≈ $35.16
-5.26%
2024-09-30 GBX305.07K
≈ $37.12
-24.04%
2023-09-30 GBX401.63K
≈ $48.87
-10.64%
2022-09-30 GBX449.47K
≈ $54.69
+1127.06%
2021-09-30 GBX36.63K
≈ $4.46
+13.56%
2020-09-30 GBX32.26K
≈ $3.92
-8.40%
2019-09-30 GBX35.22K
≈ $4.28
--

About BSF Enterprise Plc

LSE:BSFA UK Biotechnology
Market Cap
$27.33K
GBX224.66 Million GBX
Market Cap Rank
#31196 Global
#1246 in UK
Share Price
GBX1.75
Change (1 day)
-11.62%
52-Week Range
GBX0.60 - GBX3.25
All Time High
GBX21.40
About

BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom.